Searcharxiv⌕ Search

arXiv subjects

Nikolaos Ignatiadis

Publications and source records attributed to Nikolaos Ignatiadis.

28 records · Page 2Linked to original sources

Empirical partially Bayes multiple testing and compound $χ^2$ decisions

A common task in high-throughput biology is to screen for associations across thousands of units of interest, e.g., genes or proteins. Often, the data for each unit are modeled as Gaussian measurements with unknown mean and variance and are summarized as per-unit sample averages and sample variances. The downstream goal is multiple testing for the means. In this domain, it is routine to "moderate" (that is, to shrink) the sample variances through parametric empirical Bayes methods before computing p-values for the means. Such an approach is asymmetric in that a prior is posited and estimated for the nuisance parameters (variances) but not the primary parameters (means). Our work initiates the formal study of this paradigm, which we term "empirical partially Bayes multiple testing." In this framework, if the prior for the variances were known, one could proceed by computing p-values conditional on the sample variances -- a strategy called partially Bayes inference by Sir David Cox. We show that these conditional p-values satisfy an Eddington/Tweedie-type formula and are approximated at nearly-parametric rates when the prior is estimated by nonparametric maximum likelihood. The estimated p-values can be used with the Benjamini-Hochberg procedure to guarantee asymptotic control of the false discovery rate. Even in the compound setting, wherein the variances are fixed, the approach retains asymptotic type-I error guarantees.

math.ST↗

E-values as unnormalized weights in multiple testing

We study how to combine p-values and e-values, and design multiple testing procedures where both p-values and e-values are available for every hypothesis. Our results provide a new perspective on multiple testing with data-driven weights: while standard weighted multiple testing methods require the weights to deterministically add up to the number of hypotheses being tested, we show that this normalization is not required when the weights are e-values that are independent of the p-values. Such e-values can be obtained in the meta-analysis setting wherein a primary dataset is used to compute p-values, and an independent secondary dataset is used to compute e-values. Going beyond meta-analysis, we showcase settings wherein independent e-values and p-values can be constructed on a single dataset itself. Our procedures can result in a substantial increase in power, especially if the non-null hypotheses have e-values much larger than one.

stat.ME↗

Using public clinical trial reports to evaluate observational study methods

Observational studies are valuable for estimating the effects of various medical interventions, but are notoriously difficult to evaluate because the methods used in observational studies require many untestable assumptions. This lack of verifiability makes it difficult both to compare different observational study methods and to trust the results of any particular observational study. In this work, we propose TrialVerify, a new approach for evaluating observational study methods based on ground truth sourced from clinical trial reports. We process trial reports into a denoised collection of known causal relationships that can then be used to estimate the precision and recall of various observational study methods. We then use TrialVerify to evaluate multiple observational study methods in terms of their ability to identify the known causal relationships from a large national insurance claims dataset. We found that inverse propensity score weighting is an effective approach for accurately reproducing known causal relationships and outperforms other observational study methods. TrialVerify is made freely available for others to evaluate observational study methods.

stat.AP↗

Treatment Heterogeneity for Survival Outcomes

Estimation of conditional average treatment effects (CATEs) plays an essential role in modern medicine by informing treatment decision-making at a patient level. Several metalearners have been proposed recently to estimate CATEs in an effective and flexible way by re-purposing predictive machine learning models for causal estimation. In this chapter, we summarize the literature on metalearners and provide concrete guidance for their application for treatment heterogeneity estimation from randomized controlled trials' data with survival outcomes. The guidance we provide is supported by a comprehensive simulation study in which we vary the complexity of the underlying baseline risk and CATE functions, the magnitude of the heterogeneity in the treatment effect, the censoring mechanism, and the balance in treatment assignment. To demonstrate the applicability of our findings, we reanalyze the data from the Systolic Blood Pressure Intervention Trial (SPRINT) and the Action to Control Cardiovascular Risk in Diabetes (ACCORD) study. While recent literature reports the existence of heterogeneous effects of intensive blood pressure treatment with multiple treatment effect modifiers, our results suggest that many of these modifiers may be spurious discoveries. This chapter is accompanied by survlearners, an R package that provides well-documented implementations of the CATE estimation strategies described in this work, to allow easy use of our recommendations as well as the reproduction of our numerical study.

stat.AP↗

Net benefit, calibration, threshold selection, and training objectives for algorithmic fairness in healthcare

A growing body of work uses the paradigm of algorithmic fairness to frame the development of techniques to anticipate and proactively mitigate the introduction or exacerbation of health inequities that may follow from the use of model-guided decision-making. We evaluate the interplay between measures of model performance, fairness, and the expected utility of decision-making to offer practical recommendations for the operationalization of algorithmic fairness principles for the development and evaluation of predictive models in healthcare. We conduct an empirical case-study via development of models to estimate the ten-year risk of atherosclerotic cardiovascular disease to inform statin initiation in accordance with clinical practice guidelines. We demonstrate that approaches that incorporate fairness considerations into the model training objective typically do not improve model performance or confer greater net benefit for any of the studied patient populations compared to the use of standard learning paradigms followed by threshold selection concordant with patient preferences, evidence of intervention effectiveness, and model calibration. These results hold when the measured outcomes are not subject to differential measurement error across patient populations and threshold selection is unconstrained, regardless of whether differences in model performance metrics, such as in true and false positive error rates, are present. In closing, we argue for focusing model development efforts on developing calibrated models that predict outcomes well for all patient populations while emphasizing that such efforts are complementary to transparent reporting, participatory design, and reasoning about the impact of model-informed interventions in context.

stat.ML↗

Confidence Intervals for Nonparametric Empirical Bayes Analysis

In an empirical Bayes analysis, we use data from repeated sampling to imitate inferences made by an oracle Bayesian with extensive knowledge of the data-generating distribution. Existing results provide a comprehensive characterization of when and why empirical Bayes point estimates accurately recover oracle Bayes behavior. In this paper, we develop flexible and practical confidence intervals that provide asymptotic frequentist coverage of empirical Bayes estimands, such as the posterior mean or the local false sign rate. The coverage statements hold even when the estimands are only partially identified or when empirical Bayes point estimates converge very slowly.

stat.ME↗

Empirical Bayes mean estimation with nonparametric errors via order statistic regression on replicated data

We study empirical Bayes estimation of the effect sizes of $N$ units from $K$ noisy observations on each unit. We show that it is possible to achieve near-Bayes optimal mean squared error, without any assumptions or knowledge about the effect size distribution or the noise. The noise distribution can be heteroskedastic and vary arbitrarily from unit to unit. Our proposal, which we call Aurora, leverages the replication inherent in the $K$ observations per unit and recasts the effect size estimation problem as a general regression problem. Aurora with linear regression provably matches the performance of a wide array of estimators including the sample mean, the trimmed mean, the sample median, as well as James-Stein shrunk versions thereof. Aurora automates effect size estimation for Internet-scale datasets, as we demonstrate on data from a large technology firm.

stat.ME↗

Covariate powered cross-weighted multiple testing

A fundamental task in the analysis of datasets with many variables is screening for associations. This can be cast as a multiple testing task, where the objective is achieving high detection power while controlling type I error. We consider $m$ hypothesis tests represented by pairs $((P_i, X_i))_{1\leq i \leq m}$ of p-values $P_i$ and covariates $X_i$, such that $P_i \perp X_i$ if $H_i$ is null. Here, we show how to use information potentially available in the covariates about heterogeneities among hypotheses to increase power compared to conventional procedures that only use the $P_i$. To this end, we upgrade existing weighted multiple testing procedures through the Independent Hypothesis Weighting (IHW) framework to use data-driven weights that are calculated as a function of the covariates. Finite sample guarantees, e.g., false discovery rate (FDR) control, are derived from cross-weighting, a data-splitting approach that enables learning the weight-covariate function without overfitting as long as the hypotheses can be partitioned into independent folds, with arbitrary within-fold dependence. IHW has increased power compared to methods that do not use covariate information. A key implication of IHW is that hypothesis rejection in common multiple testing setups should not proceed according to the ranking of the p-values, but by an alternative ranking implied by the covariate-weighted p-values.

stat.ME↗

$σ$-Ridge: group regularized ridge regression via empirical Bayes noise level cross-validation

Features in predictive models are not exchangeable, yet common supervised models treat them as such. Here we study ridge regression when the analyst can partition the features into $K$ groups based on external side-information. For example, in high-throughput biology, features may represent gene expression, protein abundance or clinical data and so each feature group represents a distinct modality. The analyst's goal is to choose optimal regularization parameters $λ= (λ_1, \dotsc, λ_K)$ -- one for each group. In this work, we study the impact of $λ$ on the predictive risk of group-regularized ridge regression by deriving limiting risk formulae under a high-dimensional random effects model with $p\asymp n$ as $n \to \infty$. Furthermore, we propose a data-driven method for choosing $λ$ that attains the optimal asymptotic risk: The key idea is to interpret the residual noise variance $σ^2$, as a regularization parameter to be chosen through cross-validation. An empirical Bayes construction maps the one-dimensional parameter $σ$ to the $K$-dimensional vector of regularization parameters, i.e., $σ\mapsto \widehatλ(σ)$. Beyond its theoretical optimality, the proposed method is practical and runs as fast as cross-validated ridge regression without feature groups ($K=1$).

stat.ME↗

Covariate-Powered Empirical Bayes Estimation

We study methods for simultaneous analysis of many noisy experiments in the presence of rich covariate information. The goal of the analyst is to optimally estimate the true effect underlying each experiment. Both the noisy experimental results and the auxiliary covariates are useful for this purpose, but neither data source on its own captures all the information available to the analyst. In this paper, we propose a flexible plug-in empirical Bayes estimator that synthesizes both sources of information and may leverage any black-box predictive model. We show that our approach is within a constant factor of minimax for a simple data-generating model. Furthermore, we establish robust convergence guarantees for our method that hold under considerable generality, and exhibit promising empirical performance on both real and simulated data.

stat.ME↗